EnSite Real-Time Cardiac Performance Measurements (RT CPM) Study (EnSite RT CPM)
This study has been completed.
Sponsor:
St. Jude Medical
Information provided by:
St. Jude Medical
ClinicalTrials.gov Identifier:
NCT00632450
First received: February 29, 2008
Last updated: March 25, 2010
Last verified: March 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The EnSite Real-Time Cardiac Performance Measurements Study (EnSite RT CPM) is a multicenter, international, acute, non-significant risk study, designed to enroll a maximum of 40 patient. The goal of the study is to collect 3-D systolic/diastolic data with the EnSite NavX Mapping system during a CRT implant.
Patients enrolled in this study will undergo NavX CPM recording of the heart using the EnSite NavX Mapping system during the implantation of a cardiac resynchronization therapy device.
| Condition |
|---|
|
Heart Failure |
| Study Type: | Observational |
| Study Design: | Time Perspective: Prospective |
| Official Title: | EnSite Real-Time Cardiac Performance Measurements Study, a Non-significant Risk Study |
Resource links provided by NLM:
Further study details as provided by St. Jude Medical:
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Probability Sample |
Study Population
Patients indicated for implantation of a CRT pulse generator
Criteria
Inclusion Criteria:
- Be undergoing a new St. Jude Medical CRT-D or CRT-P device implantation
- Have the ability to provide informed consent for study participation and be willing to comply with the prescribed perioperative evaluations
Exclusion Criteria:
- Have a recent myocardial infarction within 40 days prior to enrollment
- Have undergone cardiac surgery or coronary revascularization procedure within 3 months prior to enrollment or be scheduled for such procedures
- Be less than 18 years of age
- Be pregnant women
- Be currently participating in a clinical study that includes an active treatment arm
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00632450
Locations
| United States, California | |
| St. Jude Medical | |
| Sunnyvale, California, United States, 94086 | |
Sponsors and Collaborators
St. Jude Medical
Investigators
| Principal Investigator: | Johannes Sperzel, MD | Kerckhoff Klinik GmbH |
| Principal Investigator: | Andre d'Avila, MD | Massachusetts General Hospital |
| Principal Investigator: | Imran Niazi, MD | Arrhythmia Center of Southern Wisconsin, Ltd |
More Information
No publications provided by St. Jude Medical
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | Michael Yang/Director of Research, St. Jude Medical |
| ClinicalTrials.gov Identifier: | NCT00632450 History of Changes |
| Other Study ID Numbers: | 40004879 |
| Study First Received: | February 29, 2008 |
| Last Updated: | March 25, 2010 |
| Health Authority: | United States: Institutional Review Board Germany: Ethics Commission |
Additional relevant MeSH terms:
|
Heart Failure Heart Diseases Cardiovascular Diseases |
ClinicalTrials.gov processed this record on May 16, 2013